Accelerating Clinical Trials in the EU: Publication of 2022-2026 workplan (Cell and Gene Therapy Catapult – Regulatory Round-up – August 2022)
On the 30th of August, the European Commission (EC), HMA and EMA published the 2022-2026 Workplan of the initiative – Accelerating Clinical Trials in the EU (ACT EU).
See all of Catapult’s Regulatory Round-up for August 2022 here.
Published on the 1st of september 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (26 octobre 2022). Accelerating Clinical Trials in the EU: Publication of 2022-2026 workplan (Cell and Gene Therapy Catapult – Regulatory Round-up – August 2022). ELSIBI. Consulté le 5 mars 2026 à l’adresse https://doi.org/10.58079/o63q





